Giovanni Gallara, Executive Vice President and Chief Clinical Services Officer of Concentra Group Holdings Parent, Inc., reported the acquisition of 53,191 shares of common stock on November 3, 2026, in a statement of changes in beneficial ownership filed on November 5, 2026.

Key Highlights

  • Reporting person: Giovanni Gallara, identified in the filing as Executive Vice President, Chief Clinical Services Officer of Concentra Group Holdings Parent, Inc.
  • Transaction date: November 3, 2026, with the filing submitted on November 5, 2026.
  • Shares acquired: 53,191 shares of common stock acquired at a price of $0, coded as an acquisition (A) in Table I.
  • Nature of grant: According to the filing, the shares represent a grant of restricted stock that "will vest in equal annual installments over four years."
  • Post-transaction ownership: Following the transaction, Gallara directly beneficially owns 166,628 shares of common stock, according to the filing.
  • Issuer and ticker: Concentra Group Holdings Parent, Inc., listed on NYSE:CON.

Gallara's Restricted Stock Grant and Ownership Position at Concentra

According to the filing, Giovanni Gallara received a grant of 53,191 shares of Concentra Group Holdings Parent, Inc. common stock on November 3, 2026. The transaction was recorded with a price of $0, consistent with an equity award rather than an open-market purchase. The filing notes that the restricted stock will vest "in equal annual installments over four years," spreading the vesting across four calendar years from the grant date.

Concentra Group Holdings Parent, Inc. (NYSE:CON) is the issuer identified on the filing's cover. Gallara holds the title of Executive Vice President, Chief Clinical Services Officer, as stated in the Remarks section of the filing. Following the reported acquisition, the filing discloses that Gallara directly holds 166,628 shares of common stock. The statement was signed by Timothy F. Ryan as Attorney-in-Fact on November 5, 2026, the same date the filing was submitted to the SEC.

No derivative securities transactions were reported in Table II of the filing. The filing was submitted by one reporting person, and no amendment date was indicated, suggesting this is an original filing rather than a revision to a previously submitted statement.

What Was Disclosed

The filing disclosed a restricted stock grant of 53,191 shares of common stock to Giovanni Gallara, Executive Vice President and Chief Clinical Services Officer of Concentra Group Holdings Parent, Inc., on November 3, 2026, bringing his total direct beneficial ownership to 166,628 shares.